Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benefits and Risks of Early Antiretroviral Treatment Initiation and 6-Months Isoniazid Prophylaxis in HIV-Infected West African Adults : a Randomized Factorial Trial (ANRS 12136 TEMPRANO)

Next Previous
X
Search
Trial Profile

Benefits and Risks of Early Antiretroviral Treatment Initiation and 6-Months Isoniazid Prophylaxis in HIV-Infected West African Adults : a Randomized Factorial Trial (ANRS 12136 TEMPRANO)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Isoniazid; Lopinavir/ritonavir
  • Indications HIV-1 infections; HIV-2 infections; Tuberculosis
  • Focus Therapeutic Use
  • Acronyms TEMPRANO

    • Most Recent Events

    • 26 Jul 2017 Results assessing association between HIV-1-DNA and mortality in HIV-infected adults presented at the 9th International AIDS Society Conference on HIV Science
    • 26 Jul 2017 Results assessing association between inflammatory/coagulation biomarkers and mortality in HIV-infected adults with high CD4 counts presented at the 9th International AIDS Society Conference on HIV Science
    • 02 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top